Announcements
Kate Rogers our new CEO
Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director
July 15, 2022
Fundraising
Thank you Ailsa – for the dance show and your donation
Wonderful Ailsa Vivian and her students at the Vivian Theatre School Dorset, who in June, raised £750 from a amazing dance show, featuring her talented
July 8, 2022
Fundraising
Fundraising – thank you Richard
In May, Richard ran 127 miles along the Leeds and Liverpool canal in under 3 days to raise funds for the FLF and show support
July 5, 2022
Research
Antibody response to CoV-2 vaccines
Interesting summary of the impact and effectiveness of antibody responses to SARS- CoV-2 vaccines in patients with hematologic malignancies. A project from Michael J. Garil
June 19, 2022
Newsletter
FLF Newsletter Q1 2022
Looking Back, Looking Forward A message from our Founder Dear Friends, Our first FLF update for the year is here and we are thrilled that
February 15, 2022
Announcements
Kate Rogers appointed as Chief Executive Officer of the Follicular Lymphoma foundation (FLF)
Today the Follicular Lymphoma Foundation (FLF) announced that Kate Rogers, currently leading the transformation of Glaxo SmithKline’s global finance organisation, as their new CEO. Kate
February 15, 2022
Articles
Blood tests in Follicular Lymphoma
For many people living with Follicular Lymphoma, periodic blood tests become a regular feature. There are several reasons you might need blood tests when affected
February 10, 2022
Articles
Everything you need to know about Follicular Lymphoma clinical trials
What are clinical trials? Any potential treatments for Follicular Lymphoma (and other forms of Non-Hodgkin lymphoma) must undergo extensive testing. They must be fully researched
January 19, 2022
Articles
ASH annual meeting 2021 round-up
At the American Society for Hematology (ASH) Annual Meeting in December 2021, the most up-to-date research was shared on Follicular Lymphoma (FL), as well as
January 18, 2022
Articles
What are clinical trials?
Any potential treatments for Follicular Lymphoma (and other forms of Non-Hodgkin lymphoma) must undergo extensive testing. They must be fully researched to confirm that they
January 18, 2022
Fundraising
“Running the Virgin Money London Marathon” by Emily Watson
On Sunday 3rd October 2021, I ran every single step of the London Marathon for Follicular Lymphoma Foundation. Words honestly cannot express the feeling of
October 27, 2021
Research
The Follicular Lymphoma Foundation research goals – patient poll results – September 2021
The FLF places the patient at the heart of our organisation. This survey collated the unmet needs and prioritised our research goals.
September 27, 2021
Interviews
Nicky Greenhalgh – Founder of Living with Follicular Lymphoma community
Lovely Nicky shares her FL story and her amazing journey which lead to her establishing the Living with Follicular Lymphoma social community Facebook – the
August 18, 2021
Announcements
Mike Thompson, Trustee of the FLF, awarded MBE
Mike Thompson, ABPI Chief Executive from 2016-2019, has been awarded an MBE for services to medicines supply resilience and development. In a statement, Mike Thompson
June 22, 2021
Announcements
The FLF announces appointment of its first chief medical officer
Dr Mitchell Smith brings to the FLF over three decades of experience focused on blood cancers. The Follicular Lymphoma Foundation (FLF) has today announced the
June 22, 2021